Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Elza Muscelli
  • Arturo Casolaro
  • Amalia Gastaldelli
  • Andrea Mari
  • Giuseppe Seghieri
  • Brenno Astiarraga
  • Yu Chen
  • Maria Alba
  • Holst, Jens Juul
  • Ele Ferrannini
Dipeptidyl peptidase IV (DPP-4) inhibitors improve glycemic control in patients with type 2 diabetes. The underlying mechanisms (incretin effect, β-cell function, endogenous glucose production) are not well known.
OriginalsprogEngelsk
TidsskriftJournal of Clinical Endocrinology and Metabolism
Vol/bind97
Udgave nummer8
Sider (fra-til)2818-26
Antal sider9
ISSN0021-972X
DOI
StatusUdgivet - aug. 2012

ID: 45841132